3 nominees · 6 ballot items.
Election of three Class I directors; ratification of KPMG LLP as independent auditor; advisory (non-binding) approval of named executive officer compensation; approval of amendments to the Certificate of Incorporation to (1) phase in declassification of the Board, (2) permit officer exculpation consistent with Delaware law, and (3) eliminate certain supermajority voting requirements.
Election of three Class I directors—Caretha Coleman, Karen Katz and Mark McCaffrey—to serve as Class I directors until the 2029 annual meeting (or until their successors are elected and qualified).
Ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Non-binding, advisory vote to approve the compensation paid to the Company’s named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and compensation tables and narrative.
This management proposal asks shareholders to cast a non-binding advisory vote approving the Company’s named executive officer (NEO) compensation as disclosed in the proxy materials, including the Compensation Discussion and Analysis, compensation tables and narrative. Management frames the vote as a broad endorsement of the Company’s overall executive pay philosophy—pay-for-performance with a meaningful proportion of compensation delivered in at‑risk annual bonuses and long‑term equity (RSUs and PSUs) tied to Adjusted EBITDA and multi-year free cash flow metrics—rather than a vote on individual pay elements. The Board and the Compensation Committee recommend a "FOR" vote, noting that the program is designed to attract and retain senior talent while aligning executive incentives with long‑term stockholder value and discouraging excessive risk (e.g., use of double‑trigger change‑in‑control arrangements, clawback policy, prohibition of single‑trigger acceleration). The proxy highlights recent outcomes (2025 bonus metrics and payouts tied to a strong Adjusted EBITDA result, continuation of PSU programs) and extensive shareholder engagement conducted after the prior say‑on‑pay vote; management says it used investor feedback to refine program design and intends to continue engagement. From a governance perspective, the advisory nature of the vote means results are not binding, but the Board commits to consider the outcome in future compensation decisions. For an analyst evaluating the proposal, key considerations include the alignment of metrics (Adjusted EBITDA and free cash flow) with strategic priorities, the balance between retention and pay-for-performance, the transparency of target performance levels (some PSU targets are withheld for competitive reasons until after performance periods end), and the level of shareholder support historically reported by the Company. The Board’s strong prior engagement and high historic say‑on‑pay support may reduce the likelihood of material investor activism, but disclosure limitations around certain PSU targets and the significant weighting of equity could be areas of shareholder concern. Overall, the proposal is a request for a non‑binding endorsement of the Company’s executive compensation framework and recent decisions, with the Board asserting that the program appropriately aligns management incentives with long‑term stockholder value.
Approve an amendment to the Amended and Restated Certificate of Incorporation to phase in declassification of the Board of Directors so that, beginning at the 2029 annual meeting, all directors will be elected annually to one‑year terms and remove certain classified‑board provisions as described in Annex I.
This management proposal seeks shareholder approval to amend the Company’s Certificate to phase out the classified (staggered) board structure and transition to annual elections for all directors by progressively converting Class I/II/III terms so that beginning with the 2028 annual meeting (and completed by the 2029 meeting) all directors will be elected annually to one‑year terms. Management argues that while a classified board historically provided continuity and defense against coercive tactics, the Company has matured and shareholder feedback favors annual elections to increase board accountability. The amendment also adjusts removal and vacancy provisions: directors will be removable without cause after the completion of the phase‑in, and vacancy appointees will, after declassification, serve only until the next annual meeting. The Board is recommending a "FOR" vote, citing prior high shareholder support for declassification proposals (≈98% of votes cast) and its corporate governance roadmap. For evaluation, key considerations include the trade‑off between continuity/stability and shareholder accountability, potential impacts on takeover defenses and director turnover, and the Company’s timeline and safeguards for a smooth transition (including grandfathering existing three‑year terms until they expire). Given the Board’s ongoing shareholder engagement and the Company’s stated commitment to governance best practices, the proposal represents a significant governance change towards increased shareholder voice and aligns the Company with common market practice of annual director elections.
Approve an amendment to the Amended and Restated Certificate of Incorporation to permit exculpation of certain officers for monetary damages for breaches of the duty of care to the fullest extent permitted by Delaware law (DGCL Section 102(b)(7) as amended).
This management proposal would amend the Company’s Certificate to incorporate the DGCL amendment that allows corporations to limit monetary liability of certain officers for breaches of the duty of care to the fullest extent permitted by law. Management frames the change as consistent with existing director exculpation provisions and as a measure to reduce inconsistent treatment between officers and directors, potentially lowering litigation and insurance costs and helping attract and retain senior talent. The amendment expressly preserves exclusions: it would not eliminate liability for breaches of the duty of loyalty, acts not in good faith, intentional misconduct, knowing violations of law, transactions conferring improper personal benefit, or derivative claims. The Board recommends a "FOR" vote, noting that the change aligns corporate documents with current Delaware statute and market practice. Analysts should weigh investor concerns about expanding exculpation for officers against corporate governance norms: while exculpation for duty of care is common and limited by statutory exceptions, increased officer protections may be viewed skeptically by some investors if not paired with robust oversight, accountability mechanisms, and clear disclosure of executive incentives and risk management.
Approve an amendment to the Amended and Restated Certificate of Incorporation to eliminate certain supermajority voting requirements and replace them with majority vote requirements for various Certificate and Bylaw amendments (as set forth in Annex III).
This management proposal would amend the Company’s Certificate to eliminate certain supermajority voting thresholds in favor of majority‑vote requirements for amendments to the Bylaws and Certificate, aligning governance with contemporary market practice that favors majority votes for most corporate actions. Management argues that removing entrenched supermajority provisions increases board accountability and enhances stockholder influence over governance changes, while preserving any vote requirements that may still be mandated by law or by the terms of any series of preferred stock. The proposal’s text replaces various 66 2/3% thresholds with a majority standard for adoption or amendment of bylaws and most Certificate provisions, while maintaining a 66 2/3% requirement for certain core protections as described in the redlined Annex. The Board recommends a "FOR" vote, presenting the change as part of the Company’s corporate governance roadmap and consistent with investor feedback. Analysts should assess potential impacts on defense against coercive transactions, changes in shareholder activism dynamics, and the Company’s current governance context (e.g., simultaneous declassification proposal). Overall, the amendment moves the Company toward greater shareholder democracy and reduces structural barriers to governance changes that require only modest majorities to enact.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | FMR LLC | 8.1% | 9,763,312 | $89M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 4,542,550 | $41M |
| 3 | TWO SIGMA INVESTMENTS, LP | 3.7% | 4,469,347 | $41M |
| 4 | BlackRock, Inc. | 3.7% | 4,411,765 | $40M |
| 5 | Divisadero Street Capital Management, LP | 3.6% | 4,342,757 | $39M |
| 6 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.4% | 4,049,042 | $37M |
| 7 | D. E. Shaw Co., Inc.Activist | 2.8% | 3,314,736 | $30M |
| 8 | BlackRock, Inc. | 2.7% | 3,254,671 | $30M |
| 9 | Qube Research Technologies Ltd | 2.7% | 3,195,482 | $29M |
| 10 | AMERICAN CENTURY COMPANIES INC | 2.5% | 2,994,474 | $27M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.